ImmunityBio - 53 Year Dividend History | IBRX

Historical dividend payout and yield for ImmunityBio (IBRX) since 1971. The current TTM dividend payout for ImmunityBio (IBRX) as of July 19, 2024 is $0.00. The current dividend yield for ImmunityBio as of July 19, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.004B $0.001B
ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.
Stock Name Country Market Cap PE Ratio